Skip to content

Lifestyle Changes by the COVID-19 (Coronavirus Disease 2019) Pandemic in Children With Developmental Delays

Lifestyle Changes by the COVID-19 (Coronavirus Disease 2019) Pandemic in Children With Developmental Delays

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05770362
Acronym
COVID-19
Enrollment
260
Registered
2023-03-15
Start date
2023-03-19
Completion date
2023-07-19
Last updated
2023-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lifestyle-related Condition, COVID-19 Pandemic, Children With Developmental Delays

Keywords

COVID-19 pandemic, lifestyle, sleep, children with developmental delays

Brief summary

To evaluate the lifestyle changes caused by the COVID-19 pandemic in children with developmental delays in Taiwan.

Detailed description

Two hundred and sixty children with developmental delays in Shin Kong Wu Ho-Su Memorial Hospital will be included. The lifestyle questionnaire will evaluate the lifestyle changes of children with developmental delays during home isolation and release from home isolation during the COVID-19 pandemic in Taiwan. The parents of children with developmental delays will fill out the questionnaire.

Interventions

The changes in lifestyle by lifestyle questionnaire during and after home isolation

Sponsors

Taipei Medical University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to 6 Years
Healthy volunteers
No

Inclusion criteria

* children diagnosed with developmental delays

Exclusion criteria

* children without developmental delays

Design outcomes

Primary

MeasureTime frameDescription
sleeping quality change by lifestyle questionnaireduring and after home isolation through study completion, an average of 6 monthsSleep quality changes during and after home isolation during the COVID-19 pandemic by lifestyle questionnaire. The minimum and maximum values range from 1 to 5; higher scores mean a worse outcome.

Countries

Taiwan

Contacts

Primary ContactRu-Lan Hsieh, MD
M001052@ms.skh.org.tw886-2-28332211
Backup ContactRu-Lan Hsieh, MD
M001052@ms.skh.org.tw

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026